Galantamine for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You had an ischemic stroke (clot-caused) within the last 3 days.
- Your stroke symptoms are moderate (score of 4–25 on a common stroke scale).
- This is your first stroke, or you had no major lasting problems from a previous stroke.
- You are willing to sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
This study tests a traditional Chinese medicine (herbal) treatment for people who have had a recent acute ischemic stroke. It will see if the herbal medicine helps improve recovery and how it works in the body, potentially offering a new treatment option.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This study tests whether a concentrated form of ginkgo, given soon after an ischemic stroke (a stroke caused by a blocked blood vessel), can help improve recovery. It's only for people who start treatment within 48 hours of symptoms, so timing is critical.
This study uses traditional Chinese medicine (TCM) diagnostic tools to evaluate patients who had an ischemic stroke within the last 10 days. It aims to understand the acute and chronic phases of stroke to help guide future treatments.
Hear when a new Acute Ischemic Stroke AIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.